A Phase 1, Randomized, Open‐Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects
2020 ◽
Vol 60
(4)
◽
pp. 701-712
◽
Detlef Albrecht
◽
Mic Iwashima
◽
Debbie Dillon
◽
Stuart Harris
◽
Jeff Levy
2019 ◽
Vol 59
(3)
◽
pp. 394-409
◽
Stephen B. Shrewsbury
◽
Maria Jeleva
◽
Kelsey H. Satterly
◽
Jason Lickliter
◽
John Hoekman
2011 ◽
Vol 60
(01)
◽
pp. 36-41
Iñaki Izquierdo
◽
Javier Borja
◽
Sandra Rovira
◽
Pilar Pelagio
◽
Ferran Torres
◽
...
Saiprasad Patil
◽
Anoop Hajare
◽
K Krishnaprasad
2009 ◽
Vol 47
(06)
◽
pp. 413-418
◽
Z. Chik
◽
R.C. Basu
◽
R. Pendek
◽
T.C. Lee
◽
Z. Mohamed
2006 ◽
Vol 44
(05)
◽
pp. 240-246
◽
J.F. Marier
◽
H. Manthos
◽
S. Kebir
◽
S. Ferron
◽
M. DiMarco
◽
...
2017 ◽
Vol 11
(3)
◽
pp. 828
Laurent Harvey
◽
Heather Jordan
◽
Pierre Lemieux
◽
Jean-Francois Lapointe
◽
Radu Pop
◽
...
2004 ◽
Vol 42
(07)
◽
pp. 373-377
◽
I.A. Alsarra
◽
M.S. Al-Said
◽
K.I. Al-Khamis
◽
E.M. Niazy
◽
Y.M. El-Sayed
◽
...
Antonio Pardo
◽
Mohammed Bouhajib
◽
Thomas R. King
◽
Eman Rafla
◽
Judith C. Kando
Jesús Cebrecos
◽
James D. Carlson
◽
Gregorio Encina
◽
Mounia Lahjou
◽
Artur Sans
◽
...
Close
Export Citation Format
Close
Share Document
Close